Available from: [18] Laukkarinen J, Sand J, Aittomki S, Prsti I, Kbi P, Kalliovalkama J, et al
3.6.2 Ferroptosis dysregulation drives RCC drug resistance Sorafenib, the first Food and Drug Administration (FDA)-approved multi-kinase inhibitor for metastatic ccRCC (253), was initially shown to induce ferroptosis by inhibiting SLC7A11 (254)
Kariuki, S
Notably, the clinical application of sodium sulfide (Na 22 S) is constrained by its suboptimal pharmacokinetic properties
The gut and brain are interconnected through the gut-brain axis, influencing immune function
Abnormalities in mitochondrial structure and defects in mitophagy have been identified in the neurons of patients with sporadic ALS (Rodriguez et al., 2012